Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

• Yen-Hsiang Huang,
• Jeng-Sen Tseng,
• Kuo-Hsuan Hsu,
• Kun-Chieh Chen,
• Kang-Yi Su,
• Sung-Liang Yu,
• Jeremy J. W. Chen,
• Tsung-Ying Yang,
• Gee-Chen Chang

Affiliations

Yen-Hsiang Huang

Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital

Jeng-Sen Tseng

Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital

Kuo-Hsuan Hsu

Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital

Kun-Chieh Chen

Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital

Kang-Yi Su

Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University

Sung-Liang Yu

Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University

Jeremy J. W. Chen

Institute of Biomedical Sciences, National Chung Hsing University

Tsung-Ying Yang

Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital

Gee-Chen Chang

Institute of Biomedical Sciences, National Chung Hsing University